Direct Measurement of Nucleoside Monophosphate Delivery from a Phosphoramidate Pronucleotide by Stable Isotope Labeling and LC−ESI--MS/MS
- 3 February 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 1 (2), 102-111
- https://doi.org/10.1021/mp0340338
Abstract
Amino acid phosphoramidates of nucleosides have been shown to be potent antiviral and anticancer agents with the potential to act as nucleoside monophosphate prodrugs. To access their ability to deliver 3‘-azido-3‘-deoxythymidine (AZT) 5‘-monophosphate to cells, the decomposition pathway of an 18O-labeled AZT amino acid phosphoramidate was investigated by capillary reverse-phase high-performance liquid chromatography interfaced with negative ion electrospray ionization mass spectrometry (LC−ESI--MS/MS). 18O-labeled l-AZT tryptophan phosphoramidate methyl ester ([18O]2) was synthesized with an 18O/16O relative ratio of 1.22 ± 0.18. For CEM cells, a human T-lymphoblast leukemia cell line, incubated with [18O]2, values of 1.55 ± 0.37, 0.34, and 0.13 were found for the 18O/16O relative ratio of intracellular AZT-MP for time intervals of 0.5, 4, and 20 h, respectively. The decrease in the level of labeled AZT-MP in CEM cells corresponded to a rapid increase in the amount of intracellular AZT presumably by dephosphorylation of AZT-MP. In contrast, for peripheral blood mononuclear cells (PBMCs), the 18O/16O relative ratio values of intracellular AZT-MP were 1.43, 1.06, and 0.61 for time intervals of 0.5, 4, and 20 h, respectively. Intracellular AZT in PBMCs was nearly undetectable for each time interval. Taken together, these results are consistent with the detection of direct P−N bond cleavage by CEM cells and PBMCs. However, AZT phosphoramidates are able to more effectively deliver AZT-MP to PBMCs than to CEM cells. Differential expression of 5‘-nucleotidase in CEM cells relative to PBMCs is likely the reason for this discrepancy. Although applied to a phosphoramidate pronucleotide, the judicious use of 18O labeling and LC−MS is a general approach that could be applied to the investigation of the intracellular fate of other pronucleotides. Keywords: Prodrugs; antiviral agent; AZT; phosphoramidateKeywords
This publication has 17 references indexed in Scilit:
- Differential Mutation Patterns in Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus Type 1 Clones Passaged in the Presence of Acyclovir or PenciclovirAntimicrobial Agents and Chemotherapy, 2003
- Pronucleotides: Toward thein vivo delivery of antiviral and anticancer nucleotidesMedicinal Research Reviews, 2000
- Intracellular Metabolism ofCycloSaligenyl 3′-Azido-2′,3′-dideoxythymidine Monophosphate, a Prodrug of 3′-Azido-2′,3′-dideoxythymidine (Zidovudine)Molecular Pharmacology, 1999
- Probing the Mechanism of Action and Decomposition of Amino Acid Phosphomonoester Amidates of Antiviral Nucleoside ProdrugsJournal of Medicinal Chemistry, 1997
- Long-Term Exposure to Zidovudine Affectsin Vitroandin Vivothe Efficiency of Phosphorylation of Thymidine KinaseAIDS Research and Human Retroviruses, 1996
- Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by the Generation of a Novel Intracellular MetaboliteJournal of Medicinal Chemistry, 1996
- Synthesis and Biological Activity of Aromatic Amino Acid Phosphoramidates of 5-Fluoro-2‘-deoxyuridine and 1-β-Arabinofuranosylcytosine: Evidence of Phosphoramidase ActivityJournal of Medicinal Chemistry, 1996
- Aromatic amino acid phosphoramidate di- and triesters of 3′-azido-3′-deoxythymidine (AZT) are non-toxic inhibitors of HIV-1 replicationBioorganic & Medicinal Chemistry Letters, 1995
- 2′,3′-Dideoxycytidine induced drug resistance in human cellsLife Sciences, 1995
- Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistanceNature, 1981